Development of cardiovascular responses to autonomic blockade in intact fetal and neonatal lambs.
D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000196:embryology / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D005333:Fetus / Q000502:physiology*; D005865:Gestational Age; D006321:Heart / Q000294:innervation; D006339:Heart Rate / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011247:Pregnancy; D011433:Propranolol / Q000494:pharmacology; D012756:Sheep; D014439:Tyramine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010276:Parasympatholytics; D010643:Phenoxybenzamine; D001285:Atropine; D011433:Propranolol; D008729:Methoxamine; D007545:Isoproterenol; D000109:Acetylcholine; D011217:Practolol; D014439:Tyramine; D010646:Phentolamine